References: 1. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010;362(8):726-738. 2. Cockerham KP, Padnick-Silver L, Stuertz N, et al. Quality of life in patients with chronic Thyroid Eye Disease in the United States. Ophthalmol Ther. 2021;10:975-987. 3. Kahaly GJ, Petrak F, Hardt J, et al. Psychosocial morbidity of Graves' orbitopathy. Clin Endocrinol (Oxf). 2005:63(4):395-402. 4. Estcourt S, Vaidya B, Quinn A, et al. The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis. Clin Endocrinol (Oxf). 2008:68(4):635-639. 5. Burch HB, Perros P, Bednarczuk T, et al. Management of Thyroid Eye Disease: a consensus statement by the American Thyroid Association and the European Thyroid Association. Thyroid. 2022;32(12):1-32.